Your browser doesn't support javascript.
loading
A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern.
Ahmed, Shahbaz; Khan, Mohammad Suhail; Gayathri, Savitha; Singh, Randhir; Kumar, Sahil; Patel, Unnatiben Rajeshbhai; Malladi, Sameer Kumar; Rajmani, Raju S; van Vuren, Petrus Jansen; Riddell, Shane; Goldie, Sarah; Girish, Nidhi; Reddy, Poorvi; Upadhyaya, Aditya; Pandey, Suman; Siddiqui, Samreen; Tyagi, Akansha; Jha, Sujeet; Pandey, Rajesh; Khatun, Oyahida; Narayan, Rohan; Tripathi, Shashank; McAuley, Alexander J; Singanallur, Nagendrakumar Balasubramanian; Vasan, Seshadri S; Ringe, Rajesh P; Varadarajan, Raghavan.
Afiliação
  • Ahmed S; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Khan MS; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Gayathri S; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Singh R; Mynvax Private Limited, ES12, Entrepreneurship Centre, Society for Innovation and Development (SID), Indian Institute of Science, Bengaluru, India.
  • Kumar S; Virology Unit, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Chandigarh, India.
  • Patel UR; Mynvax Private Limited, ES12, Entrepreneurship Centre, Society for Innovation and Development (SID), Indian Institute of Science, Bengaluru, India.
  • Malladi SK; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Rajmani RS; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • van Vuren PJ; Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), Geelong, VIC, Australia.
  • Riddell S; Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), Geelong, VIC, Australia.
  • Goldie S; Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), Geelong, VIC, Australia.
  • Girish N; Mynvax Private Limited, ES12, Entrepreneurship Centre, Society for Innovation and Development (SID), Indian Institute of Science, Bengaluru, India.
  • Reddy P; Mynvax Private Limited, ES12, Entrepreneurship Centre, Society for Innovation and Development (SID), Indian Institute of Science, Bengaluru, India.
  • Upadhyaya A; Mynvax Private Limited, ES12, Entrepreneurship Centre, Society for Innovation and Development (SID), Indian Institute of Science, Bengaluru, India.
  • Pandey S; Mynvax Private Limited, ES12, Entrepreneurship Centre, Society for Innovation and Development (SID), Indian Institute of Science, Bengaluru, India.
  • Siddiqui S; Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi, India.
  • Tyagi A; Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi, India.
  • Jha S; Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi, India.
  • Pandey R; INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) Laboratory, Council of Scientific and Industrial Research (CSIR)-Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
  • Khatun O; Department of Microbiology & Cell Biology, Indian Institute of Science, Bengaluru, India.
  • Narayan R; Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.
  • Tripathi S; Department of Microbiology & Cell Biology, Indian Institute of Science, Bengaluru, India.
  • McAuley AJ; Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.
  • Singanallur NB; Department of Microbiology & Cell Biology, Indian Institute of Science, Bengaluru, India.
  • Vasan SS; Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.
  • Ringe RP; Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), Geelong, VIC, Australia.
  • Varadarajan R; Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), Geelong, VIC, Australia.
Front Immunol ; 12: 765211, 2021.
Article em En | MEDLINE | ID: mdl-34956193
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article